Anxiolytic effects of royal sun medicinal mushroom, agaricus brasiliensis (higher basidiomycetes) on ischemia-induced anxiety in rats

International Journal of Medicinal Mushrooms

Volumn 17, Issue 1, 2015, Pages 1-10

  Zhang, Chunjing ^a   Gao, Xiulan ^b   Sun, Yan ^a   Sun, Xiaojie ^a   Wu, Yanmin ^a   Liu, Ying ^c   Yu, Haitao ^a   Cui, Guangcheng ^a  

^a QIQIHAR MEDICAL UNIVERSITY   (China)

^b Shandong College of Chinese Medicine   (China)

^c Heilongjiang Nursing College   (China)

Author keywords

Agaricus brasiliensis; Anxiety; Cerebral ischemic reperfusion; Corticosterone; Extrapyramidal symptom; Medicinal mushrooms; Monoamine

Indexed keywords

AGARICUS BRASILIENSIS EXTRACT; CATALASE; CORTICOSTERONE; DOPAMINE; FUNGAL EXTRACT; GLUTATHIONE; GLUTATHIONE PEROXIDASE; GLUTATHIONE REDUCTASE; GLUTATHIONE TRANSFERASE; LACTATE DEHYDROGENASE; LIPID PEROXIDASE; NORADRENALIN; SEROTONIN; UNCLASSIFIED DRUG; ANXIOLYTIC AGENT; PLANT EXTRACT;

AGARICUS; AGARICUS BRASILIENSIS; ANIMAL EXPERIMENT; ANIMAL MODEL; ANXIETY; ARTICLE; BRAIN INFARCTION SIZE; BRAIN ISCHEMIA; CATALEPSY; CONTROLLED STUDY; ELEVATED PLUS MAZE TEST; EXPLORATORY BEHAVIOR TEST; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; LASER DOPPLER FLOWMETRY; MALE; MEDICINAL MUSHROOM; MIDDLE CEREBRAL ARTERY OCCLUSION; MOTOR DYSFUNCTION; NONHUMAN; OXIDATIVE STRESS; RAT; ROTA ROD TEST; SOCIAL INTERACTION TEST; TRANQUILIZING ACTIVITY; ANIMAL; ANIMAL BEHAVIOR; CHEMISTRY; COMPLICATION; DRUG EFFECTS; DRUG THERAPY; HUMAN; ISCHEMIA; METABOLISM; PSYCHOLOGY; WISTAR RAT;

AGARICUS BRASILIENSIS; ANIMALIA; BASIDIOMYCOTA; RATTUS;

AGARICUS; ANIMALS; ANTI-ANXIETY AGENTS; ANXIETY; BEHAVIOR, ANIMAL; HUMANS; ISCHEMIA; MALE; OXIDATIVE STRESS; PLANT EXTRACTS; RATS; RATS, WISTAR;

EID: 84922389770     PISSN: 15219437     EISSN: 19404344     Source Type: Journal    
DOI: 10.1615/IntJMedMushrooms.v17.i1.10     Document Type: Article

References (42)

1. Wang J, Liu YM, Cao W, Yao KW, Liu ZQ, Guo JY. Anti-inflammation and antioxidant effect of Cordymin, a peptide purifed from the medicinal mushroom Cordy-ceps sinensis, in middle cerebral artery occlusion-induced focal cerebral ischemia in rats. Metab Brain Dis. 2012;27:159–65.
2. Ghoge H, Sharma S, Sonawalla S, Parikh R. Cerebro-vascular diseases and depression. Curr Psychiatry Rep. 2003;5:231–38.
3. Whyte EM, Mulsant BH. Post stroke depression: epidemiology, pathophysiology, and biological treatment. Biol Psychiatry. 2002;52:253–64.
4. Dhooper A, Young C, Reid KH. Ischemia-induced anxiety following cardiac arrest in the rat. Behav Brain Res. 1997;84:57–62.
5. Burvill PW, Johnson GA, Jamrozik KD, Anderson CS, Stewart-Wynne EG, Chakera TMH. Anxiety disorders after stroke: results from the Perth Community Stroke Study. Br J Psychiatry. 1995;166:328–32.
6. Castillo CS, Starkstein SE, Fedoroff JP, Price TR, Robinson RG. Generalized anxiety disorder after stroke. J Nerv Ment Dis. 1993;181:100–6.
7. Firenzuoli F, Gori L, Lombardo G. The medicinal mushroom Agaricus brasiliensis Murrill: Review of literature and pharmaco-toxicological problems. Evid Based Complement Alternat Med. 2008;5:3–15.
8. Wasser SP. Medicinal mushroom science: history, current status, future trends, and unsolved problems. Int J Med Mushrooms. 2010;12:1–16.
9. Lo HC, Wasser SP. Medicinal mushrooms for glycemic control in diabetes mellitus: history, current status, future perspectives, and unsolved problems (review). Int J Med Mushrooms. 2011;13:401–26.
10. Chang ST, Wasser SP. The role of culinary-medicinal mushrooms on human welfare with pyramid model for human health. Int J Med Mushrooms. 2012;14:95–134.
11. Geethangili M, Tzeng YM. Review of pharmacological effects of Antrodia camphorata and its bioactive compounds. Evid Based Complement Alternat Med. 2011:212641.
12. Wasser SP, Didukh M.Ya., de Amazonas MAA, Nevo E, Stamets P, da Eira AF. Is a widely cultivated culinary-medicinal royal sun Agaricus (the Himematsutake mushroom) indeed Agaricus blazei Murrill? Int J Med Mushrooms. 2002;4:267–90.
13. Wasser SP, Didukh M.Ya., de Amazonas MA, Nevo E, Stamets P, da Eira AF. Is a widely cultivated culinary-medicinal royal sun Agaricus (champignon do Brazil, or the himematsutake mushroom) Agaricus brasiliensis S. Wasser et al. indeed a synonym of A. subrufescens Peck? Int J Med Mushrooms. 2005;7:507–11.
14. Hsu CH, Liao YL, Lin SC. The mushroom Agaricus brasiliensis in combination with metformin and glicla-zide improves insulin resistance in type 2 diabetes: A randomized,double-blind and placebo-controlled clinical trial. J Altern Complement Med. 2007;13:97–102.
15. Chen L, Shao HJ, Su YB. Coimmunization of Agaricus brasiliensis extract with hepatitis B virus core protein through DNA vaccine enhances cellular and humoral immune responses. Int Immunopharmacol. 2004;4:403–9.
16. Hsu CH, Hwang KC, Chiang YH, Chou P. The mushroom Agaricus blazei Murrill extract normalizes liver function in patients with chronic hepatitis B. J Altern Complement Med. 2008;14:299–301.
17. Liu Z, Li P, Zhao D, Tang H, Guo J. Protection by vanadium, a contemporary treatment approach to both diabetes and focal cerebral ischemia in rats. Biol Trace Elem Res. 2012;145:66–70.
18. Liu Z, Li P, Zhao D, Tang H, Guo J. Protective effect of extract of Cordyceps sinensis in middle cerebral artery occlusion-induced focal cerebral ischemia in rats. Behav Brain Funct. 2010,6:61.
19. Bernardshaw S, Johnson E, Hetland G. An extract of the mushroom Agaricus blazei Murrill administered orally protects against systemic Streptococcus pneumoniae infection in mice. Scand J Immunol. 2005;62:393–98.
20. Zhang S, He B, Ge J, Zhai C, Liu X, Liu P. Characterization of chemical composition of Agaricus brasiliensis polysaccharides and its effect on myocardial SOD activity, MDA and caspase-3 level in ischemia-reperfusion rats. Int J Biol Macromol. 2010;46:363–66.
21. Costa CA, Kohn DO, de Lima VM, Gargano AC, Flório JC, Costa M, The GABAergic system contributes to the anxiolytic-like effect of essential oil from Cymbopogon ci-tratus (lemongrass). J Ethnopharmacol. 2011;137:828–36.
22. Shah ZA, Namiranian K, Klaus J, Kibler K, Dore S. Use of an optimized transient occlusion of the middle cerebral artery protocol for the mouse stroke model. J Stroke Cerebrovasc Dis. 2006;15:133–38.
23. Frye CA, Petralia SM, Rhodes ME. Estrous cycle and sex differences in performance on anxiety tasks coincide with increases in hippocampal progesterone and 3α,5α-THP. Pharmacol Biochem Behav. 2000;67:587–96.
24. Lister RG, The use of a plus-maze to measure anxiety in the mouse. Psychopharmacology (Berl). 1987;92:180–5.
25. Nagai H, Egashira N, Sano K, Ogata A, Mizuki A, Mishi-ma K. Antipsychotics improve Δ9-tetrahydrocannabinol-induced impairment of the prepulse inhibition of the startle refex in mice. Pharmacol Biochem Behav. 2006;84:330–36.
26. Bao L, Yao XS, Yau CC, Tsi D, Chia CS, Nagai H, Kuri-hara H. Protective effects of bilberry (Vaccinium myrtil-lus L.) extract on restraint stress-induced liver damage in mice. J Agric Food Chem. 2008;56:7803–7.
27. Bao L, Yao XS, Zhao L, Lu YQ, Kurihara H. Correlation between changes of central neurotransmitter expression and stress response in mice–a restraint time-course analysis. Neural Regeneration Res. 2008;3:167–71.
28. Woodward CJ, Emery PW. Determination of plasma cor-ticosterone using high-performance liquid chromatogra-phy. J Chromatogr. 1988;419:280–84.
29. Lum G, Gambino SR. A comparison of serum vs heparin-ized plasma for routine chemistry tests. Am J Clin Pathol. 1974;61:108–13.
30. Liu Z, Li P, Zhao D, Tang H, Guo J. Anti-inflammation effects of Cordyceps sinensis mycelium in focal cerebral ischemic injury rats. Infammation. 2011;34:639–44.
31. Valko M, Leibfritz D, Moncol J, Cronin MTD, Mazur M, Telser J. Free radicals and antioxidants in normal physiological functions and human disease. Int J Biochem Cell B. 2007;39:44–84.
32. Handley SL, McBlane JW. An assessment of the elevated X-maze for studying anxiety and anxiety-modulating drugs. J Pharmacol Toxicol Methods. 1993;29:129–38.
33. Rodgers RJ, Cole JC. The elevated plus-maze pharmacology, methodology and ethology. In: Cooper SJ, Hen-drie CA, editors. Ethology and Psychopharmacology. Chichester (UK): John Wiley & Sons Ltd., 1994, p. 5–44.
34. Nakashima N, Ajiki K, Nakashima K, Takahashi M. Possible role of nitric oxide in anxiety following transient cerebral ischemia in mice. J Pharmacol Sci. 2003;91:47–52.
35. Guo JY, Li CY, Ruan YP, Sun M, Qi XL, Zhao BS, Luo F. Chronic treatment with celecoxib reverses chronic unpredictable stress-induced depressive-like behavior via reducing cyclooxygenase-2 expression in rat brain. Eur J Pharmacol. 2009;612:54–60.
36. Kent JM, Mathew SJ, Gorman JM. Molecular targets in the treatment of anxiety. Biol Psychiatry. 2002;52:1008–30.
37. Halliwell B. Oxidative stress and neurodegeneration: where are we now? J Neurochem. 2006;97:1634–58.
38. Cardozo PF, Song S, Parthasarathy A, Hazzi C, Naidu K, Ramos RJ. Oxidative DNA damage in the aging mouse brain. Mov Disord. 1999;14:972–80.
39. Ng F, Berk M, Dean O, Bush AI. Oxidative stress in psychiatric disorders: Evidence base and therapeutic implications. Int J Neuropsychopharmacol. 2008;11:851–76.
40. Kuloglu M, Atmaca M, Tezcan E, Gecici O, Tunckol H, Ustundag B. Antioxidant enzyme activities and malondi-aldehyde levels in patients with obsessive-compulsive disorder. Neuropsychobiol. 2002;46:27–32.
41. Casey DE. Tardive dyskinesia and atypical antipsychotic drugs. Schizophr Res. 1999;35:S61–66.
42. Pemminati S, Nair V, Dorababu P, Gopalakrishna HN, Pai M. Effect of ethanolic leaf extract of Ocimum sanctum on haloperidol-induced catalepsy in albino mice. Indian J Pharmacol. 2007;39:87–89.